uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Show others and affiliations
2017 (English)In: Peptides, ISSN 0196-9781, E-ISSN 1873-5169, Vol. 87, p. 20-27Article in journal (Refereed) Published
Abstract [en]

Brain region-specific expression of proteolytic enzymes can control the biological activity of endogenous neuropeptides and has recently been targeted for the development of novel drugs, for neuropathic pain, cancer, and Parkinson's disease. Rapid and sensitive analytical methods to profile modulators of enzymatic activity are important for finding effective inhibitors with high therapeutic value. Combination of in situ enzyme histochemistry with MALDI imaging mass spectrometry allowed developing a highly sensitive method for analysis of brain-area specific neuropeptide conversion of synthetic and endogenous neuropeptides, and for selection of peptidase inhibitors that differentially target conversion enzymes at specific anatomical sites. Conversion and degradation products of Dynorphin B as model neuropeptide and effects of peptidase inhibitors applied to native brain tissue sections were analyzed at different brain locations. Synthetic dynorphin B (2 pmol) was found to be converted to the N-terminal fragments on brain sections whereas fewer C-terminal fragments were detected. N-ethylmaleimide (NEM), a non-selective inhibitor of cysteine peptidases, almost completely blocked the conversion of dynorphin B to dynorphin B(1-6; Leu-Enk-Arg), (1-9), (2-13), and (7-13). Proteinase inhibitor cocktail, and also incubation with acetic acid displayed similar results. Bioconversion of synthetic dynorphin B was region-specific producing dynorphin B(1-7) in the cortex and dynorphin B (2-13) in the striatum. Enzyme inhibitors showed region-and enzyme-specific inhibition of dynorphin bioconversion. Both phosphoramidon (inhibitor of the known dynorphin converting enzyme neprilysin) and opiorphin (inhibitor of neprilysin and aminopeptidase N) blocked cortical bioconversion to dynorphin B(1-7), wheras only opiorphin blocked striatal bioconversion to dynorphin B(2-13). This method may impact the development of novel therapies with aim to strengthen the effects of endogenous neuropeptides under pathological conditions such as chronic pain. Combining histochemistry and MALDI imaging MS is a powerful and sensitive tool for the study of inhibition of enzyme activity directly in native tissue sections. (C) 2016 The Authors. Published by Elsevier Inc.

Place, publisher, year, edition, pages
2017. Vol. 87, p. 20-27
Keywords [en]
Neuropeptide, Dynorphin, Bioconversion, Enzyme, Enzyme inhibitor, Histochemistry, MALDI imaging mass spectrometry, Mass spectrometry, Parkinson's disease, Neuropathic pain
National Category
Pharmaceutical Sciences Biochemistry and Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-316129DOI: 10.1016/j.peptides.2016.11.006ISI: 000392684000003PubMedID: 27840228OAI: oai:DiVA.org:uu-316129DiVA, id: diva2:1080578
Available from: 2017-03-10 Created: 2017-03-10 Last updated: 2018-01-13Bibliographically approved

Open Access in DiVA

fulltext(1638 kB)224 downloads
File information
File name FULLTEXT01.pdfFile size 1638 kBChecksum SHA-512
e0dfc76033d2bb28573ba5700b21885ace198f0feecbe7df9854ed622d34d44d4d3743272e8b0c44bc954d88e2696ccb0c0bf68175437211a215e0866d67d7d3
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Bergquist, JonasBakalkin, GeorgyAndersson, Malin

Search in DiVA

By author/editor
Bivehed, ErikBergquist, JonasBakalkin, GeorgyAndersson, Malin
By organisation
Department of Pharmaceutical BiosciencesAnalytical Chemistry
In the same journal
Peptides
Pharmaceutical SciencesBiochemistry and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 224 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 1024 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf